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The effect of L-asparaginase in treatment of certain 
types of leukemia is now well established. The history 
of Lasparaginase as a therapeutic agent has been re- 
viewed by Broome [l] . Recently, immunosuppressive 
properties of the enzyme have been reported [2,3]. 
A 900-fold purification of Lasparaginase from 
guinea pig serum was obtained by Yellin and Wriston 
[4] after a series of steps involving sodium sulfate 
fractionation, gel filtration on Sephadex G-200, and 
chromatography on DEAEcellulose and hydroxyl- 
apatite. The two distinct asparaginases EC-l and EC-2 
of E. co/i have been purified from cell-free extracts 
by Campbell et al. [5] who used similar procedures, 
and by Roberts et al. [6] by means of ethanol fractio- 
nation, chromatography on DEAE-cellulose and CM- 
Sephadex, and polyacrylamide electrophoresis. Whelan 
and Wriston [7] reported a 2000-fold purification of 
E. coli B asparaginase by heat denaturation, gel fil- 
tration, chromatography on DEAE-cellulose and hy- 
droxylapatite, and polyacrylamide electrophoresis. 
Large-scale purification of EC-2 for clinical use at 
present requires a costly multi-step process giving a 
product which is only partially pure. 
We believe that techniques developed in our labo- 
ratory [S-l l] might lead to a faster and simpler pu- 
rification method based on specific adsorption and 
desorption on a matrix to which an inhibitor had been 
covalently bound. Reversible inhibition by D-asparagine 
or Lasparaginase from Micobactetium phlei was re- 
ported by Grossowicz and Halpern [ 121, and rat liver 
and guinea pig liver asparaginases were found by De- 
Groot and Lichtenstein [ 131 to be inhibited by a series 
of ol-A’-alkyl derivatives of DL-asparagine. Mor and 
Lichtenstein [ 141 showed that carbobenzoxy deriva- 
tives of L- and DL-phenylalanine, Ltyrosine, and L- 
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cysteine were competitive inhibitors of rat liver aspa- 
raginase. Our first attempt to prepare an adsorbent for 
E. coli asparaginase was by direct coupling of D-aspa- 
ragine by way of the amino group, using the CNBr 
method. The coupling was successful but the product 
did not adsorb any enzyme. We have found that direct 
coupling of small molecules nearly always leads to 
adsorbents of low efficiency. One of the probable 
reasons is that the close proximity to the matrix of the 
active molecule reduces the probability of complement- 
ary specific sites being brought into sufficiently close 
contact. To overcome this problem, we decided to in- 
sert a spacer molecule between D-asparagine and the 
carbohydrate matrix. We settled for a procedure in- 
volving the following steps: 
Step 1. By a Walden conversion L (+)P-chlorosuc- 
cinamic acid was prepared by treatment of D(-)-as- 
paragine with nitrous acid in a large excess of sodium 
chloride [ 151: 
H2N-CH-COOH 
I 
BNO Cl-C H-COOH 
? I 
H,C -CONH, NaCl H,C -CONH2 
Step 2. As spacers, we used putrescine (n = 4) or 
hexamethylenediamine (n = 6) in large excess. These 
were reacted with chlorosuccinamic acid to form a 
monoamino derivative: 
H2N-(CH2),,-NH2 + Cl-CH-COOH 
I 
H2C -CONH2 
30-4o” 
H2N-(CH,),-NH-CH-COOH + HCl 
70-80 
I 
H,C -CONH, 
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Step 3. Coupling of the monoamino derivative by 
way of the free amino group to Sepharose 6B (Phar- 
macia Fine Chemicals, Upp.sala, Sweden) by the CNBr 
method. 
The best results o far have been obtained with 
hexamethylenediamine as aspacer, in which case the 
adsorbent was prepared as follows: 2.6 g chlorosuc- 
cinamic acid obtained in step 1 was added to 10 g 
melted hexamethylenediamine at 40’ and the mixture 
left for 80 hr with stirring. To improve the yield and 
reduce elimination of Cl- from chlorosuccinamic a id 
by hydrolysis leading to formation of maleamic acid 
[IS], no water was added during step 2. The oily reac- 
tion product was concentrated under vacuum from a 
large excess of water in a Btichi rotating evaporator at 
40’ three times in succession. To the final volume of 
15 ml, 40 ml 0.5 M NaHCO, was added. Due to the 
strong basic@ of the derivative, the solution had to be 
adjusted to pH 8.5 with HCl before addition to 100 
ml Sepharose 6B, representing 6 g dry gel, which had 
been activated with 6 g CNBr as described previously 
[ 111. The suspension was gently rocked overnight at 
room temperature and then washed extensively at pH 
8.5 and 3.0 on a Biichner funnel. A column 32 X 45 mm 
(36 ml) was filled with adsorbent and cycled several 
times between pH 3.0 and 8.5. 
Lyophilized E. coli cells (Strain B, Worthington ECB 
6HA) were disrupted in a 10 kc Raytheon ultrasonic 
disintegrator and an aliquot of the supematant extract 
applied to the adsorbent column at a rate of 16 ml/hr. 
The elution curve is shown in fig. 1. Asparaginase ac- 
tivity was assayed by the phenate-hypochlorite method 
[16] (Berthelot reaction) which proved much easier to 
handle and gave more consistent results than the Nessler 
procedure. We used a ready-made r agent kit (Harnstoff- 
Farb-Test TC-UR-II) purchased from C.F.Boehringer 
and Sohne, Mannheim, W.Germany. When putrescine 
was used as a spacer, the corresponding adsorbent re- 
tarded most of the asparaginase activity so strongly 
that a fair separation between active and inactive ma- 
terial was obtained. In 0.05 M borate buffer pH 8.6, 
a decrease in salt concentration led to an increase in 
affinity both for active and inactive material, whereas 
a higher salt concentration caused insufficient separa- 
tion of asparaginase activity from the bulk of extracted 
material. Evidence for specific interaction between en- 
zyme and adsorbents based on both types of spacers 
is provided by the fact that no selective retardation of 
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Fig. 1. Elution of L-asparaginase from specific adsorbent. 
Buffer during adsorption phase: 0.05 M borate, containing 
0.3 M NaCl and 0.006% NaN3, pH 8.6. Desorption with 10-3 
M D-aspaagine in buffer started at Dl, desorption of residual 
non-specifically bound material with 2 M NaCl in buffer 
started at D2. Broken line indicates asparaginase activity. 
asparaginase activity was obtained in the presence of 
1 O-3 M D-asparagine in buffer and sample during the 
run, whereas 10m3 M Lglutamine barely affected 
retardation. Due to the small amount of enzyme so 
far isolated, the specific activity of the purified as- 
paraginase has not been established with certainty. It 
is at least IO4 units/mg but may be much higher. This 
value compares favourably with non-specifically puri- 
fied enzyme till now reported in the literature. 
A crucial question concerning the feasibility of 
large-scale production of L-asparaginase according to 
the method described is the rate of hydrolysis of the 
amide group on the adsorbent. Campbell and Mash- 
burn [ 17 ] found that D-asparagine in free solution 
was hydrolysed by EC-2 asparaginase at 6% the rate 
of Lasparagine at the optimum pH 7.4, decreasing to 
5.5% at pH 8.6. The present adsorbent column has 
been put through a series of more than ten adsorp 
tiondesorption cycles with no obvious reduction in 
capacity. A decrease in retardation of the enzyme 
can be counteracted by lowering the ionic strength 
at the cost of increased non-specific adsorption. How- 
ever, desorption with D-asparagine strongly favours 
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the release of enzyme, and residual non-specifically 
adsorbed material can be desorbed with 2 M NaCl 
prior to the next cycle. Experiments aimed at optimiz- 
ing conditions are now under way with a 3 1 column; 
a detailed report of this will appear elsewhere. 
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